首页> 外文期刊>Respiratory medicine >Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis.
【24h】

Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis.

机译:扩展的NO分析适用于COPD,过敏性哮喘和过敏性鼻炎患者。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The recommended method to measure exhaled nitric oxide (NO) cannot reveal the source of NO production. We applied a model based on the classical Fick's first law of diffusion to partition NO in the lungs. The aim was to develop a simple and robust solution algorithm with a data quality control feature, and apply it to patients with known alterations in exhaled NO. Subjects with allergic rhinitis, allergic asthma, chronic obstructive pulmonary disease (COPD) smokers and controls were investigated. NO was measured at three expiratory flow rates. An iteration method was developed to partition NO. The airway tissue content of NO was increased in asthma, 144 +/- 80 ppb (P = 0.04) and decreased in smokers, 56 +/- 36 ppb (P = 0.02). There was no difference between subjects with rhinitis, 98 +/- 40 ppb and controls, 98 +/- 44 ppb. The airway transfer rate was increased in allergic asthma and allergic rhinitis, 12 +/- 4 vs. 12 +/- 5 ml sec(-1), compared to controls, 8 +/- 2 ml sec(-1) (P < 0.001). The alveolar levels were no different from controls, 2 +/- 1 ppb. In COPD the alveolar levels were increased, 4 +/- 2 ppb (P < 0.001). Extended NO analysis reveals from where in the respiratory system NO is generated. Hence, this new test can be added to the tools the physician has for the diagnosis and treatment of patients with respiratory disorders.
机译:推荐的呼出气一氧化氮(NO)测量方法无法揭示NO产生的来源。我们应用了基于经典菲克第一扩散定律的模型来分配NO在肺中。目的是开发一种具有数据质量控制功能的简单而强大的解决方案算法,并将其应用于呼出气NO已知变化的患者。调查了患有过敏性鼻炎,过敏性哮喘,慢性阻塞性肺疾病(COPD)吸烟者和对照组的受试者。在三个呼气流速下测得NO。开发了一种迭代方法来划分NO。哮喘患者的气道组织NO含量增加了144 +/- 80 ppb(P = 0.04),而吸烟者降低了56 +/- 36 ppb(P = 0.02)。鼻炎受试者98 +/- 40 ppb与对照受试者98 +/- 44 ppb之间没有差异。在过敏性哮喘和过敏性鼻炎中,气道传输速率增加,与对照组的8 +/- 2 ml sec(-1)相比,增加了12 +/- 4 vs. 12 +/- 5 ml sec(-1)(P < 0.001)。肺泡水平与对照组无差异,为2 +/- 1 ppb。在COPD中,肺泡水平增加了4 +/- 2 ppb(P <0.001)。扩展的NO分析揭示了在呼吸系统中的何处生成了NO。因此,可以将该新测试添加到医师用于诊断和治疗呼吸系统疾病患者的工具中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号